Quantifying Drug‐Induced Bone Marrow Toxicity Using a Novel Haematopoiesis Systems Pharmacology Model
Open Access
- 11 September 2019
- journal article
- research article
- Published by Wiley in CPT: Pharmacometrics & Systems Pharmacology
- Vol. 8 (11) , 858-868
Abstract
Haematological toxicity associated with cancer therapeutics is monitored by changes in blood cell count, and their primary effect is on proliferative progenitors in the bone marrow. Using observations in rat bone marrow and blood, we characterize a mathematical model that comprises cell proliferation and differentiation of the full haematopoietic phylogeny, with interacting feedback loops between lineages in homeostasis as well as following carboplatin exposure. We accurately predicted the temporal dynamics of several mature cell types related to carboplatin‐induced bone marrow toxicity and identified novel insights into haematopoiesis. Our model confirms a significant degree of plasticity within bone marrow cells, with the number and type of both early progenitors and circulating cells affecting cell balance, via feedback mechanisms, through fate decisions of the multipotent progenitors. We also demonstrated cross‐species translation of our predictions to patients, applying the same core model structure and considering differences in drug‐dependent and physiology‐dependent parameters.Keywords
This publication has 50 references indexed in Scilit:
- Dynamic niches in the origination and differentiation of haematopoietic stem cellsNature Reviews Molecular Cell Biology, 2011
- Factors for Hematopoietic Toxicity of Carboplatin: Refining the Targeting of Carboplatin Systemic ExposureJournal of Clinical Oncology, 2010
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Hematopoietic stem cell: self‐renewal versus differentiationWIREs Mechanisms of Disease, 2010
- Hematopoiesis and its disorders: a systems biology approachBlood, 2010
- Population pharmacokinetic and pharmacodynamic analysis to support treatment optimization of combination chemotherapy with indisulam and carboplatinBritish Journal of Clinical Pharmacology, 2008
- Pharmacodynamic model for chemotherapy-induced anemia in ratsCancer Chemotherapy and Pharmacology, 2007
- Epo and other hematopoietic factorsSeminars in Fetal and Neonatal Medicine, 2007
- Allometric Scaling of the Active Hematopoietic Stem Cell Pool across MammalsPLOS ONE, 2006
- Hematopoietic Stem CellsThe American Journal of Pathology, 2006